Deploying a robust continuous improvement methodology is especially beneficial in the earliest phases of drug development. It can help ensure the delivery of high-quality, reliable, timely bioanalytical and clinical data to make informed decisions about either moving on to the next drug development milestone or pivoting to another strategy.
The post Continuous Process Improvement: The Secret to Navigating Early-Phase Drug Development appeared first on MedCity News.
Bengali (Bangladesh) · 
English (United States) ·